Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis

Fabien Bernard Vincent; Stephan Pavy; Roman Krzysiek; Thierry Lequerré; Jérémie Sellam; Yassine Taoufik; Xavier Mariette; Corinne Miceli-Richard

doi:10.1016/j.jbspin.2015.07.015

Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis

Fabien Bernard Vincent, Stephan Pavy, Roman Krzysiek, Thierry Lequerré, Jérémie Sellam, Yassine Taoufik, Xavier Mariette, Corinne Miceli-Richard

Immunology Alfred Hospital

Research output: Contribution to journal › Letter › Research › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	595-597
Number of pages	3
Journal	Joint Bone Spine
Volume	83
Issue number	5
DOIs	https://doi.org/10.1016/j.jbspin.2015.07.015
Publication status	Published - 1 Oct 2016

Keywords

Anti tumour necrosis factor (TNF)
Antidrug antibodies (ADAb)
Axial spondyloarthritis (AS)
Rheumatoid arthritis (RA)

Access to Document

10.1016/j.jbspin.2015.07.015

Cite this

Vincent, F. B., Pavy, S., Krzysiek, R., Lequerré, T., Sellam, J., Taoufik, Y., Mariette, X., & Miceli-Richard, C. (2016). Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis. Joint Bone Spine, 83(5), 595-597. https://doi.org/10.1016/j.jbspin.2015.07.015

@article{c49675f2b5ad4742a554cf683a38c6b0,

title = "Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis",

keywords = "Anti tumour necrosis factor (TNF), Antidrug antibodies (ADAb), Axial spondyloarthritis (AS), Rheumatoid arthritis (RA)",

author = "Vincent, {Fabien Bernard} and Stephan Pavy and Roman Krzysiek and Thierry Lequerr{\'e} and J{\'e}r{\'e}mie Sellam and Yassine Taoufik and Xavier Mariette and Corinne Miceli-Richard",

year = "2016",

month = oct,

day = "1",

doi = "10.1016/j.jbspin.2015.07.015",

language = "English",

volume = "83",

pages = "595--597",

journal = "Joint Bone Spine",

issn = "1297-319X",

publisher = "Elsevier",

number = "5",

}

Vincent, FB, Pavy, S, Krzysiek, R, Lequerré, T, Sellam, J, Taoufik, Y, Mariette, X & Miceli-Richard, C 2016, 'Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis', Joint Bone Spine, vol. 83, no. 5, pp. 595-597. https://doi.org/10.1016/j.jbspin.2015.07.015

Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis. / Vincent, Fabien Bernard; Pavy, Stephan; Krzysiek, Roman et al.
In: Joint Bone Spine, Vol. 83, No. 5, 01.10.2016, p. 595-597.

Research output: Contribution to journal › Letter › Research › peer-review

TY - JOUR

T1 - Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis

AU - Vincent, Fabien Bernard

AU - Pavy, Stephan

AU - Krzysiek, Roman

AU - Lequerré, Thierry

AU - Sellam, Jérémie

AU - Taoufik, Yassine

AU - Mariette, Xavier

AU - Miceli-Richard, Corinne

PY - 2016/10/1

Y1 - 2016/10/1

KW - Anti tumour necrosis factor (TNF)

KW - Antidrug antibodies (ADAb)

KW - Axial spondyloarthritis (AS)

KW - Rheumatoid arthritis (RA)

UR - http://www.scopus.com/inward/record.url?scp=84975503566&partnerID=8YFLogxK

U2 - 10.1016/j.jbspin.2015.07.015

DO - 10.1016/j.jbspin.2015.07.015

M3 - Letter

AN - SCOPUS:84975503566

SN - 1297-319X

VL - 83

SP - 595

EP - 597

JO - Joint Bone Spine

JF - Joint Bone Spine

IS - 5

ER -

Vincent FB, Pavy S, Krzysiek R, Lequerré T, Sellam J, Taoufik Y et al. Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis. Joint Bone Spine. 2016 Oct 1;83(5):595-597. doi: 10.1016/j.jbspin.2015.07.015

Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis

Keywords

Access to Document

Other files and links

Cite this